Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections

Abstract Background Malaria infections are often genetically diverse, potentially leading to competition between co-infecting strains. Such competition is of key importance in the spread of drug resistance. Methods The effects of drug treatment on within-host competition were studied using the roden...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Read Andrew F, Bell Andrew S, Culleton Richard, de Roode Jacobus C
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2004
Subjects:
Online Access:https://doi.org/10.1186/1475-2875-3-33
https://doaj.org/article/fb0297d72adb428aa9422f80436e10d5
Description
Summary:Abstract Background Malaria infections are often genetically diverse, potentially leading to competition between co-infecting strains. Such competition is of key importance in the spread of drug resistance. Methods The effects of drug treatment on within-host competition were studied using the rodent malaria Plasmodium chabaudi . Mice were infected simultaneously with a drug-resistant and a drug-sensitive clone and were then either drug-treated or left untreated. Transmission was assessed by feeding mice to Anopheles stephensi mosquitoes. Results In the absence of drugs, the sensitive clone competitively suppressed the resistant clone; this resulted in lower asexual parasite densities and also reduced transmission to the mosquito vector. Drug treatment, however, allowed the resistant clone to fill the ecological space emptied by the removal of the sensitive clone, allowing it to transmit as well as it would have done in the absence of competition. Conclusion These results show that under drug pressure, resistant strains can have two advantages: (1) they survive better than sensitive strains and (2) they can exploit the opportunities presented by the removal of their competitors. When mixed infections are common, such effects could increase the spread of drug resistance.